Functional mechanism of neuroprotection by inhibitors of type B monoamine oxidase in Parkinson’s disease

Neurochemical Approaches in the Laboratory Diagnosis of Parkinson and Parkinson Dementia Syndromes: A Review

(2009) Sarah Jesse et al.   CNS Neuroscience & Therapeutics

Parkinson's disease: from monogenic forms to genetic susceptibility factors

(2009) S. Lesage et al.   HUMAN MOLECULAR GENETICS

Gene-Gene Interaction Between FGF20 and MAOB in Parkinson Disease

(2008) X. Gao et al.   ANNALS OF HUMAN GENETICS

Identification, Expression Pattern, and Characterization of Mouse Glutaredoxin 2 Isoforms

(2008) Christoph Hudemann et al.   ANTIOXIDANTS & REDOX SIGNALING

Synergistic effects of selegiline and donepezil on cognitive impairment induced by amyloid beta (25–35)

(2008) H TSUNEKAWA et al.   BEHAVIOURAL BRAIN RESEARCH

Structural and Mechanistic Studies of Arylalkylhydrazine Inhibition of Human Monoamine Oxidases A and B†‡

(2008) Claudia Binda et al.   BIOCHEMISTRY

Synthesis, structure–activity relationships and molecular modeling studies of new indole inhibitors of monoamine oxidases A and B

(2008) Giuseppe La Regina et al.   BIOORGANIC & MEDICINAL CHEMISTRY

Neuroprotection by rasagiline in thiamine deficient rats

(2008) Sarah Eliash et al.   BRAIN RESEARCH

The neuroprotective effect of ladostigil against hydrogen peroxide-mediated cytotoxicity

(2008) Orly Weinreb et al.   CHEMICO-BIOLOGICAL INTERACTIONS

The increasing role of monoamine oxidase type B inhibitors in Parkinson's disease therapy

(2008) Lawrence W Elmer et al.   EXPERT OPINION ON PHARMACOTHERAPY

Parkinson’s disease: genetic versus toxin-induced rodent models

(2008) Mügen Terzioglu et al.   FEBS Journal

TVP1022 and Propargylamine Protect Neonatal Rat Ventricular Myocytes Against Doxorubicin-Induced and Serum Starvation-Induced Cardiotoxicity

(2008) Yana Kleiner et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY

The Novel Cholinesterase–Monoamine Oxidase Inhibitor and Antioxidant, Ladostigil, Confers Neuroprotection in Neuroblastoma Cells and Aged Rats

(2008) Orit Bar-Am et al.   JOURNAL OF MOLECULAR NEUROSCIENCE

Anti-apoptotic effect of Mao-B inhibitor PF9601N [N-(2-propynyl)-2-(5-benzyloxy-indolyl) methylamine] is mediated by p53 pathway inhibition in MPP+-treated SH-SY5Y human dopaminergic cells

(2008) Elisenda Sanz et al.   JOURNAL OF NEUROCHEMISTRY

Comparison of neuroprotective and neurorestorative capabilities of rasagiline and selegiline against lactacystin-induced nigrostriatal dopaminergic degeneration

(2008) Wen Zhu et al.   JOURNAL OF NEUROCHEMISTRY

Neuromelanin selectively induces apoptosis in dopaminergic SH-SY5Y cells by deglutathionylation in mitochondria: involvement of the protein and melanin component

(2008) Makoto Naoi et al.   JOURNAL OF NEUROCHEMISTRY

Brain Monoamine Oxidase A Activity Predicts Trait Aggression

(2008) N. Alia-Klein et al.   JOURNAL OF NEUROSCIENCE

Mitochondrial Dysfunction, Oxidative Stress, and Apoptosis Revealed by Proteomic and Transcriptomic Analyses of the Striata in Two Mouse Models of Parkinson’s Disease

(2008) Mark H. Chin et al.   JOURNAL OF PROTEOME RESEARCH

Safety and tolerability of intraputaminal delivery of CERE-120 (adeno-associated virus serotype 2–neurturin) to patients with idiopathic Parkinson's disease: an open-label, phase I trial

(2008) William J Marks et al.   LANCET NEUROLOGY

Polymorphism in environment responsive genes and association with Parkinson disease

(2008) Madhu Singh et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

Fas-associated factor 1 and Parkinson's disease

(2008) Ranjita Betarbet et al.   NEUROBIOLOGY OF DISEASE

1-Methyl-4-phenyl-pyridinium ion-induced oxidative stress, c-Jun phosphorylation and DNA fragmentation factor-45 cleavage in SK-N-SH cells are averted by selegiline

(2008) Banthit Chetsawang et al.   NEUROCHEMISTRY INTERNATIONAL

Selegiline reduces cisplatin-induced neuronal death in neuroblastoma cells

(2008) Thomas Müller et al.   NEUROLOGICAL RESEARCH

Neural progenitor cells are protected against MPTP by MAO-B inhibitors

(2008) Xi Jun He et al.   NEUROTOXICOLOGY

MAO-B Elevation in Mouse Brain Astrocytes Results in Parkinson's Pathology

(2008) Jyothi K. Mallajosyula et al.   PLoS One

Structure of human monoamine oxidase A at 2.2-A resolution: The control of opening the entry for substrates/inhibitors

(2008) S.-Y. Son et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

A Dual Role of the NF-κB Pathway in Neonatal Hypoxic-Ischemic Brain Damage

(2008) Cora H. Nijboer et al.   STROKE

Rasagiline is neuroprotective in a transgenic model of multiple system atrophy

(2007) Nadia Stefanova et al.   EXPERIMENTAL NEUROLOGY

Targeting multiple Alzheimer’s disease etiologies with multimodal neuroprotective and neurorestorative iron chelators

(2007) Tamar Amit et al.   FASEB JOURNAL

Genetic findings in Parkinson’s disease and translation into treatment: a leading role for mitochondria?

(2007) V. Bogaerts et al.   GENES BRAIN AND BEHAVIOR

Monoamine oxidase: isoforms and inhibitors in Parkinson's disease and depressive illness

(2006) Moussa B H Youdim et al.   BRITISH JOURNAL OF PHARMACOLOGY